Postmenopausal hormone use and secondary prevention of coronary events in the nurses' health study. a prospective, observational study.

PubWeight™: 1.44‹?› | Rank: Top 5%

🔗 View Article (PMID 11434726)

Published in Ann Intern Med on July 03, 2001

Authors

F Grodstein1, J E Manson, M J Stampfer

Author Affiliations

1: Channing Laboratory, 181 Longwood Avenue, Boston, MA 02115, USA.

Associated clinical trials:

Nurses' Health Study (Cardiovascular Component) | NCT00005152

Articles citing this

Vitamin D insufficiency. Mayo Clin Proc (2011) 2.89

Vascular actions of estrogens: functional implications. Pharmacol Rev (2008) 2.52

Timing of hormone therapy, type of menopause, and coronary disease in women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation. Menopause (2011) 2.06

The role of estrogens in control of energy balance and glucose homeostasis. Endocr Rev (2013) 1.93

Increased longevity in older users of postmenopausal estrogen therapy: the Leisure World Cohort Study. Menopause (2006) 1.46

Hormone therapy and risk of cardiovascular outcomes and mortality in women treated with statins. Menopause (2015) 1.45

The Women's international study of long-duration oestrogen after menopause (WISDOM): a randomised controlled trial. BMC Womens Health (2007) 1.07

Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes. Am J Med (2011) 1.02

Total estrogen time and obstructive coronary disease in women: insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE). J Womens Health (Larchmt) (2009) 1.00

Sex, stroke, and inflammation: the potential for estrogen-mediated immunoprotection in stroke. Horm Behav (2012) 0.99

Preventive effects of phytoestrogens against postmenopausal osteoporosis as compared to the available therapeutic choices: An overview. J Nat Sci Biol Med (2011) 0.96

Results of observational studies: analysis of findings from the Nurses' Health Study. PLoS One (2014) 0.91

Estrogen, vascular estrogen receptor and hormone therapy in postmenopausal vascular disease. Biochem Pharmacol (2013) 0.90

Parenteral oestrogen in the treatment of prostate cancer: a systematic review. Br J Cancer (2008) 0.86

Vascular effects of estrogenic menopausal hormone therapy. Rev Recent Clin Trials (2012) 0.85

Vascular Aging in Women: is Estrogen the Fountain of Youth? Front Physiol (2012) 0.85

Hormone replacement therapy and the breast. BMJ (2001) 0.84

Changes of the prescription of hormone therapy in menopausal women: an observational study in Taiwan. BMC Public Health (2007) 0.84

Computational investigation of the binding mode of bis(hydroxylphenyl)arenes in 17β-HSD1: molecular dynamics simulations, MM-PBSA free energy calculations, and molecular electrostatic potential maps. J Comput Aided Mol Des (2011) 0.81

Hormone Replacement Therapy for Primary and Secondary Prevention of Heart Disease. Curr Treat Options Cardiovasc Med (2003) 0.79

Frequency of symptoms and health seeking behaviours of menopausal women in an out-patient clinic in Port Harcourt, Nigeria. Glob J Health Sci (2013) 0.79

Postmenopausal hormone replacement therapy for primary prevention of cardiovascular and cerebrovascular disease. Recommendation statement from the Canadian Task Force on Preventive Health Care. CMAJ (2004) 0.78

Tips for teachers of evidence-based medicine: adjusting for prognostic imbalances (confounding variables) in studies on therapy or harm. J Gen Intern Med (2008) 0.75

Postmenopausal hormonal therapy: Current status. Indian J Endocrinol Metab (2013) 0.75

Doctor, should I take hormones? Perm J (2005) 0.75

Exogenous Hormone Use: Oral Contraceptives, Postmenopausal Hormone Therapy, and Health Outcomes in the Nurses' Health Study. Am J Public Health (2016) 0.75

Is "cardiovascular protection" by estrogens due to inhibition of the sympathetic nervous system? Clin Auton Res (2005) 0.75

Articles by these authors

Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol (1985) 26.13

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med (1997) 18.85

Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol (1992) 17.17

Total energy intake: implications for epidemiologic analyses. Am J Epidemiol (1986) 16.34

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA (2001) 15.85

Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med (2001) 14.48

The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med (1995) 11.08

Body weight and mortality among women. N Engl J Med (1995) 11.04

Food-based validation of a dietary questionnaire: the effects of week-to-week variation in food consumption. Int J Epidemiol (1989) 10.98

Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol (1986) 10.84

Validity of self-reported waist and hip circumferences in men and women. Epidemiology (1990) 10.57

Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol (1994) 9.90

Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc (1993) 9.90

Aspirin and the risk of colorectal cancer in women. N Engl J Med (1995) 9.59

Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol (1999) 9.34

Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. Eur Heart J (1985) 9.28

Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med (2000) 9.05

Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med (1990) 8.98

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. N Engl J Med (1991) 8.66

Prospective study of alcohol consumption and risk of coronary disease in men. Lancet (1991) 8.64

Annual deaths attributable to obesity in the United States. JAMA (1999) 8.62

A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA (1995) 8.60

Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med (1996) 8.57

Test of the National Death Index. Am J Epidemiol (1984) 8.46

Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med (1997) 8.43

Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation (2000) 8.17

The Nurses' Health Study: 20-year contribution to the understanding of health among women. J Womens Health (1997) 8.00

Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet (1991) 7.87

Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med (1995) 7.62

Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care (1994) 7.11

Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA (1998) 7.09

Reproducibility and validity of dietary patterns assessed with a food-frequency questionnaire. Am J Clin Nutr (1999) 7.02

Plasma organochlorine levels and the risk of breast cancer. N Engl J Med (1997) 7.02

Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA (1997) 6.92

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science (1998) 6.50

Test of the National Death Index and Equifax Nationwide Death Search. Am J Epidemiol (1994) 6.47

The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med (2001) 6.37

Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med (1993) 6.37

Physical activity and television watching in relation to risk for type 2 diabetes mellitus in men. Arch Intern Med (2001) 6.23

Abdominal adiposity and coronary heart disease in women. JAMA (1998) 6.21

Dietary fiber and the risk of colorectal cancer and adenoma in women. N Engl J Med (1999) 6.17

A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med (1990) 6.06

A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med (1993) 5.87

Triggering of sudden death from cardiac causes by vigorous exertion. N Engl J Med (2000) 5.63

The assessment of alcohol consumption by a simple self-administered questionnaire. Am J Epidemiol (1991) 5.60

Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med (1995) 5.42

Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med (1994) 5.42

Vitamin E consumption and the risk of coronary disease in women. N Engl J Med (1993) 5.39

The use of a self-administered questionnaire to assess diet four years in the past. Am J Epidemiol (1988) 5.32

Tubal ligation, hysterectomy, and risk of ovarian cancer. A prospective study. JAMA (1993) 5.31

Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst (1999) 5.27

A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med (2000) 5.17

Prospective study of major dietary patterns and risk of coronary heart disease in men. Am J Clin Nutr (2000) 5.17

A prospective cohort study of vasectomy and prostate cancer in US men. JAMA (1993) 5.09

Birthweight as a risk factor for breast cancer. Lancet (1996) 5.05

Intake of trans fatty acids and risk of coronary heart disease among women. Lancet (1993) 5.00

Postmenopausal hormone therapy and mortality. N Engl J Med (1997) 4.96

A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med (1995) 4.94

Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol (1997) 4.84

Dual effects of weight and weight gain on breast cancer risk. JAMA (1997) 4.81

Dietary fat and fiber in relation to risk of breast cancer. An 8-year follow-up. JAMA (1992) 4.80

Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range. JAMA (1995) 4.78

Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst (1998) 4.74

Menopause and the risk of coronary heart disease in women. N Engl J Med (1987) 4.70

Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst (1996) 4.66

Weight as a risk factor for clinical diabetes in women. Am J Epidemiol (1990) 4.64

A prospective study of walking as compared with vigorous exercise in the prevention of coronary heart disease in women. N Engl J Med (1999) 4.61

A prospective study of passive smoking and coronary heart disease. Circulation (1997) 4.51

A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA (1997) 4.50

Birth weight and risk of cardiovascular disease in a cohort of women followed up since 1976. BMJ (1997) 4.49

Birthweight and the risk for type 2 diabetes mellitus in adult women. Ann Intern Med (1999) 4.49

Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care (1997) 4.46

Cigarette smoking, relative weight, and menopause. Am J Epidemiol (1983) 4.46

Walking compared with vigorous physical activity and risk of type 2 diabetes in women: a prospective study. JAMA (1999) 4.43

A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women. Am J Clin Nutr (2000) 4.38

Reproducibility and validity of a self-administered physical activity questionnaire for male health professionals. Epidemiology (1996) 4.37

Smoking cessation and decreased risk of stroke in women. JAMA (1993) 4.36

Pharmacotherapy for obesity -- do the benefits outweigh the risks? N Engl J Med (1996) 4.32